10-04 :: April 2010

nanotimes

Companies

Facts

Under the terms of the agreement, MagForce may offer these tranches from time-to-time, pursuant to the terms of the agreement. The purchase price of newly issued shares shall be determined by a formula based on the market price of MagForce’s stock. The commitment provides MagForce with flexible access to additional equity capital of up to EUR20 million, thus ensuring that the company retains a sound basis of financial comfort as it enters the rapidly approa- ching commercialization phase and further expands its R&D pipeline.

German MagForce Nanotechnologies is a world-lea- ding company in the area of nanotechnology-based cancer treatment. Its patented Nano-Cancer®

is able to display high-definition video content. It will also cut down on energy consumption by 80% compared to the previous screen.

http://global.mitsubishielectric.com

M

therapy

enables the targeted destruction of tumors using su- perparamagnetic nanoparticles to generate heat. The nanotechnology from MagForce represents a revolu- tionary approach to the future successful treatment of solid tumors.

http://www.magforce.de

M

itsubishi Electric Corporation (TOKYO SE: 6503) has completed installation of a

Diamond Vision large-scale LED display system at KKWING in Kumamoto City, Japan. The new 600- inch screen replaced the previous electric discharge tube screen installed 10 years ago, providing brighter and higher resolution live videos for the visitors of the Kumamoto Prefecture‘s multiple-use athletics stadium and also one of the main home stadiums for the J2 soccer team Roasso Kumamoto.

Incorporating high-luminance light-emitting diodes (LEDs) aligned vertically and horizontally in a 12.5-millimeter dot pitch and the latest digital screen controllers, the new 13.2 meter × 7.6 meter screen

yriant Technologies LLC (as successor to BioEnergy International), a leading biotech

developer and manufacturer of renewable bioche- micals, has been selected by the U.S. Department of Energy (DOE) to receive up to $50 million for its planned biobased Succinic Acid facility in Louisiana. Notably, among the 19 integrated biorefinery pro- jects that won funding or loan guarantees, Myriant was the only award focused exclusively on biobased chemicals rather than biofuels.

http://www.myriant.com

N

anoH2O, a global provider of membranes for

desalination and water reuse, has been awar-

ded a $400,000 grant from the U.S. Office of Naval Research (ONR) to evaluate its high-flux membranes for ship- board desalination systems. Tests con- ducted by ONR at the U.S. Navy Seawater Desalination Test Facility at Port Hueneme in Califor- nia will accelerate NanoH2

O’s research into fouling

resistance as well as the optimization of desalination systems for high-flux operations. This research will also provide a benchmark for comparing NanoH2

breakthrough technology to existing reverse osmosis (RO) membranes.

“NanoH2O’s ultimate objective is to alter the fun- damental economics of commercial desalination by

O’s

27